| Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway | |
| Yu, Peng; Xu, Xi; Zhang, Jing; Xia, Xuan; Xu, Fen; Weng, Jianping; Lai, Xiaoyang; Shen, Yunfeng | |
| 刊名 | INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
 |
| 2019 | |
| ISSN号 | 1687-8337 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3598956 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Yu, Peng,Xu, Xi,Zhang, Jing,et al. Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway[J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY,2019. |
| APA | Yu, Peng.,Xu, Xi.,Zhang, Jing.,Xia, Xuan.,Xu, Fen.,...&Shen, Yunfeng.(2019).Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. |
| MLA | Yu, Peng,et al."Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway".INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论